RATIONALE: Mindfulness relaxation, a technique to help patients quiet their thoughts and relax their bodies before and during chemotherapy, may reduce or prevent nausea and vomiting. It may also help improve mental health, quality of life, and immune function in patients receiving chemotherapy. PURPOSE: This randomized clinical trial is studying mindfulness relaxation to see how well it works compared to relaxing music or standard symptom management education in treating patients who are receiving chemotherapy for newly diagnosed solid tumors.
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Conditioned nausea and vomiting as measured by Morrow assessment of nausea and emesis (MANE)
Timeframe: Up to 12 months post treatment
Distress as measured by Impact of Event Scale (IES)
Timeframe: Up to 12 months post treatment
Fatigue as measured by brief fatigue inventory (BFI)
Timeframe: Up to 12 months post treatment
Anxiety as measured by Spielberger State/Trait Anxiety Scale (STAI)
Timeframe: Up to 12 months post treatment
Depression as measured by Center for Epidemiology-Depression (CES-D)
Timeframe: Up to 12 months post treatment
Sleep as measured by Pittsburgh Sleep Quality Index (PSQI)
Timeframe: Up to 12 months post treatment
Pain as measured by brief pain inventory (BPI)
Timeframe: Up to 12 months post treatment
Quality of life as measured by Functional Assessment of Cancer Therapy
Timeframe: Up to 12 months post treatment